Literature DB >> 31610143

In-vitro evaluation of a dual carbapenem combination against carbapenemase-producing Acinetobacter baumannii.

Patrice Nordmann1, Julien Perler2, Nicolas Kieffer2, Laurent Poirel3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31610143     DOI： 10.1016/j.jinf.2019.10.003

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  3 in total

Review 1.  In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations.

Authors:  Stamatis Karakonstantis; Petros Ioannou; Diamantis D Kofteridis
Journal:  Infection       Date:  2022-01-04       Impact factor: 3.553

2.  Effectiveness of a double-carbapenem combinations against carbapenem-resistant Gram-negative bacteria.

Authors:  Jiayue Lu; Yan Qing; Ning Dong; Congcong Liu; Yu Zeng; Qiaoling Sun; Qiao Shentu; Lixing Huang; Yingqian Wu; Hongwei Zhou; Zhangqi Shen; Rong Zhang
Journal:  Saudi Pharm J       Date:  2022-03-14       Impact factor: 4.562

3.  Efficacy of dual carbapenem treatment in a murine sepsis model of infection due to carbapenemase-producing Acinetobacter baumannii.

Authors:  T Cebrero-Cangueiro; P Nordmann; M Carretero-Ledesma; J Pachón; M E Pachón-Ibáñez
Journal:  J Antimicrob Chemother       Date:  2021-02-11       Impact factor: 5.790
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.